CoreCap Advisors LLC Makes New Investment in CME Group Inc. (NASDAQ:CME)

CoreCap Advisors LLC acquired a new stake in shares of CME Group Inc. (NASDAQ:CME) during the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 2,010 shares of the financial services provider’s stock, valued at approximately $395,000.

Other institutional investors also recently bought and sold shares of the company. Gold Investment Management Ltd. acquired a new stake in CME Group during the 4th quarter worth about $26,000. Salomon & Ludwin LLC acquired a new stake in shares of CME Group during the first quarter worth about $28,000. Y.D. More Investments Ltd purchased a new stake in CME Group in the second quarter valued at approximately $36,000. McClarren Financial Advisors Inc. boosted its position in CME Group by 66.1% in the second quarter. McClarren Financial Advisors Inc. now owns 196 shares of the financial services provider’s stock valued at $39,000 after buying an additional 78 shares during the last quarter. Finally, Asset Dedication LLC increased its holdings in CME Group by 515.2% in the 2nd quarter. Asset Dedication LLC now owns 203 shares of the financial services provider’s stock worth $40,000 after buying an additional 170 shares during the period. 87.75% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity at CME Group

In other CME Group news, Director Bryan T. Durkin sold 7,593 shares of the stock in a transaction that occurred on Friday, August 30th. The stock was sold at an average price of $214.59, for a total transaction of $1,629,381.87. Following the completion of the transaction, the director now owns 55,607 shares of the company’s stock, valued at $11,932,706.13. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. 0.30% of the stock is currently owned by corporate insiders.

CME Group Stock Down 0.1 %

CME Group stock opened at $216.99 on Friday. The company has a debt-to-equity ratio of 0.10, a current ratio of 1.02 and a quick ratio of 1.02. The stock has a market capitalization of $78.13 billion, a PE ratio of 24.69, a price-to-earnings-growth ratio of 8.85 and a beta of 0.55. The business has a 50 day simple moving average of $205.69 and a 200-day simple moving average of $207.59. CME Group Inc. has a 12 month low of $190.70 and a 12 month high of $223.80.

CME Group (NASDAQ:CME) last released its quarterly earnings results on Wednesday, July 24th. The financial services provider reported $2.56 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.53 by $0.03. The firm had revenue of $1.53 billion for the quarter, compared to analysts’ expectations of $1.53 billion. CME Group had a net margin of 56.98% and a return on equity of 12.82%. The firm’s revenue for the quarter was up 12.7% compared to the same quarter last year. During the same quarter last year, the company earned $2.30 EPS. On average, analysts anticipate that CME Group Inc. will post 9.94 EPS for the current fiscal year.

CME Group Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Wednesday, September 25th. Investors of record on Monday, September 9th will be given a dividend of $1.15 per share. The ex-dividend date of this dividend is Monday, September 9th. This represents a $4.60 annualized dividend and a dividend yield of 2.12%. CME Group’s dividend payout ratio (DPR) is presently 52.33%.

Analyst Upgrades and Downgrades

Several analysts have recently commented on the stock. JPMorgan Chase & Co. upped their price objective on shares of CME Group from $187.00 to $191.00 and gave the company an “underweight” rating in a report on Thursday, July 25th. Deutsche Bank Aktiengesellschaft upped their price target on shares of CME Group from $193.00 to $200.00 and gave the company a “hold” rating in a report on Thursday, August 15th. Bank of America cut CME Group from a “neutral” rating to an “underperform” rating and decreased their price objective for the company from $212.00 to $177.00 in a report on Tuesday, September 3rd. Piper Sandler restated an “overweight” rating and issued a $225.00 target price on shares of CME Group in a research note on Tuesday, August 20th. Finally, Barclays boosted their price target on CME Group from $208.00 to $209.00 and gave the company an “equal weight” rating in a report on Thursday, July 25th. Four research analysts have rated the stock with a sell rating, five have assigned a hold rating and three have assigned a buy rating to the company’s stock. According to MarketBeat, the company currently has an average rating of “Hold” and a consensus price target of $209.73.

CME Group Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.